Pfizer, Moderna, Novavax Roll Out New COVID-19 Vaccines

Pfizer, Moderna, and Novavax have launched updated COVID-19 vaccines aimed at combating the currently circulating variants.

Pfizer and Moderna: Both companies have revised their mRNA vaccines to specifically target the Omicron variant KP.2 strain, maintaining protection against severe illness, hospitalization, and death.

Novavax: Offering a protein-based alternative to mRNA vaccines, Novavax’s updated vaccine also targets the Omicron variant, providing another option for those seeking robust protection.

toledocitypaper.com/the-city/pfizer-moderna-novavax-roll-out-new-covid-19-vaccines/

www.fda.gov/news-events/press-announcements/fda-approves-and-authorizes-updated-mrna-covid-19-vaccines-better-protect-against-currently